Biolidics

Biolidics to issue 98.5 mil shares at subscription price of 1.19 cents per share - THE EDGE SINGAPORE

Company in the news

Biolidics to issue 98.5 mil shares at subscription price of 1.19 cents per share

The new subscription agreement will come to a total of $1,172,150.

Medtech

Biolidics raises $1.5 million from investor

Biolidics raises $1.5 million from new investor to repay debt
Biolidics raising $1.5 million by issuing new shares to investor from China - THE EDGE SINGAPORE

Equity raising

Biolidics raising $1.5 million by issuing new shares to investor from China

The new shares will be issued at 50% discount off Biolidic's last traded price

Company in the news

UOB will no longer sponsor Biolidics after Dec 31

The Covid-19 test kit provider is currently “actively seeking” to appoint a new sponsor.
Biolidics: Pushing the frontiers of medical tech - THE EDGE SINGAPORE

kopi-C: the Company brew

Biolidics: Pushing the frontiers of medical tech

Biolidics is a tech-driven company that offers promising technology for oncology precision medicine.

Covid-19

Biolidics to start production of ClearEpi NAB Test

Commercial production for the ClearEpi NAB Test is expected to start before the year-end.

Covid-19

Singapore company Biolidics in talks to distribute Covid-19 test kits: PhillipCapital

In March 2020, the Singapore-based medical technology company launched its IgC/IgM antibody test kit for Covid-19.

Covid-19

Regulators keep watch as companies jump on Covid-19 bandwagon

Healthcare companies are now in the spotlight as the Covid-19 pandemic continues. Listed companies such as Biolidics and Q&M Dental Group have announced their intention to produce Covid-19 test kits. And markets have reacted accordingly.

Covid-19

Singapore firm Biolidics to launch rapid test kit to detect Covid-19 within 10 minutes

Singapore firm Biolidics launches a rapid test kit that will identify confirmed cases of Covid-19 within 10 minutes.

Equity raising

Biolidics issues 17.9 mil shares in placement exercise to raise $3.1 mil

Biolidics issues 17.9 mil shares at 17.5 cents per share in placement exercise to raise $3.1 mil
×